NCT04597359 2026-03-23
To Evaluate if Green Tea Can be Effective in Reducing the Progression of Prostate Cancer in Men on Close Monitoring
Eastern Cooperative Oncology Group
Phase 2 Active not recruiting
Clinical Trials
8 trialsNCT00088946 2020-07-31
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Completed
NCT00596011 2019-10-04
Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT00666562 2017-11-17
Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00253643 2017-04-18
Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer
OHSU Knight Cancer Institute
Phase NA Completed
NCT00459407 2014-10-08
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
National Cancer Institute (NCI)
Phase 1 Completed
NCT00676780 2012-08-08
Green Tea Extract and Prostate Cancer
Louisiana State University Health Sciences Center Shreveport
Phase 2 Completed
NCT01340599 2012-03-15
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery
Case Comprehensive Cancer Center
Phase 2 Terminated